Rhy Norton, MS is a molecular biologist and lab manager at Dynamic DNA Laboratories, where he oversees development of clinical and consumer genetic tests in a CAP-accredited, CLIA-compliant lab. With over a decade of experience in molecular microbiology, Rhy has contributed to numerous peer-reviewed studies on gene expression, microbial resistance, and the human microbiome.
In early 2025, he launched one of the first psychedelic-focused DNA panels in the U.S., helping to explore how individual genetics may impact the metabolism, efficacy, and safety of psychedelic compounds. This work builds on his broader passion for personalized medicine and pharmacogenomics.
Rhy holds a master’s in biology from Missouri State University and has trained and mentored dozens of young scientists. He is committed to bridging science and spirit in the evolving field of psychedelic medicine, with an emphasis on data integrity, accessibility, and patient-centered care.
